Single-Domain Antibodies Efficiently Neutralize SARS-CoV-2 Variants of Concern

MLA

Irina A. Favorskaya, et al. “Single-Domain Antibodies Efficiently Neutralize SARS-CoV-2 Variants of Concern.” Frontiers in Immunology, vol. 13, Feb. 2022. EBSCOhost, https://doi.org/10.3389/fimmu.2022.822159.

APA

Irina A. Favorskaya, Dmitry V. Shcheblyakov, Ilias B. Esmagambetov, Inna V. Dolzhikova, Irina A. Alekseeva, Anastasia I. Korobkova, Daria V. Voronina, Ekaterina I. Ryabova, Artem A. Derkaev, Anna V. Kovyrshina, Anna A. Iliukhina, Andrey G. Botikov, Olga L. Voronina, Daria A. Egorova, Olga V. Zubkova, Natalia N. Ryzhova, Ekaterina I. Aksenova, Marina S. Kunda, Denis Y. Logunov, … Alexandr L. Gintsburg. (2022). Single-Domain Antibodies Efficiently Neutralize SARS-CoV-2 Variants of Concern. Frontiers in Immunology, 13. https://doi.org/10.3389/fimmu.2022.822159

Chicago

Irina A. Favorskaya, Dmitry V. Shcheblyakov, Ilias B. Esmagambetov, Inna V. Dolzhikova, Irina A. Alekseeva, Anastasia I. Korobkova, Daria V. Voronina, et al. 2022. “Single-Domain Antibodies Efficiently Neutralize SARS-CoV-2 Variants of Concern.” Frontiers in Immunology 13 (February). doi:10.3389/fimmu.2022.822159.